Minor role of hepatitis B and C virus infection in the etiology of hepatocellular carcinoma in a low-endemic area

Scandinavian Journal of Gastroenterology

Volumn 31, Issue 8, 1996, Pages 809-813

  Kaczynski, J ^a   Hansson, G ^a   Hermodsson, S ^a   Olsson, R ^a   Wallerstedt, S ^a  

^a Dept of Medicine ^*

Author keywords

Alcoholism; Etiology; Hepatitis B; Hepatitis C; hepatocellular carcinoma; Sweden

Indexed keywords

ALCOHOL; HEPATITIS B CORE ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; AGED; ALCOHOLISM; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; ENDEMIC DISEASE; FEMALE; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; IMMUNOASSAY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SWEDEN;

EID: 0030056020     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529609010357     Document Type: Article

References (40)

1. Cook GC. Hepatocellular carcinoma: one of the world's most common malignancies [editorial]. Q J Med 1985;233:705-8.
2. Vitale GC, Heuser LS, Polk HC. Malignant tumors of the liver. Surg Clin North Am 1986;66:723-41.
3. The Cancer Registry. Cancer incidence in Sweden 1958-1974. Stockholm: National Board of Health and Welfare, 1960-1982.
4. Beasley RP. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 1988;61:1942-56.
5. Kaczynski J, Hansson G, Norkrans G, Wallerstedt S. Lack of correlation between hepatitis B virus infection and the increasing incidence of primary liver cancer in Sweden. Acta Oncol 1991;30:811-3.
6. de Franchis R, Meucci G, Vecchi M, Tatarella M, Colombo M, Del Ninno E, et al. The natural history of asymptomatic hepatitis B surface antigen carriers. Ann Intern Med 1993;118:191-4.
7. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244: 359-62.
8. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990;12: 641-75.
9. Yuki N, Hayashi N, Kasahara A, Hagiwara H, Katayama K, Fusamoto H, et al. Hepatitis B virus markers and antibodies to hepatitis C virus in Japanese patients with hepatocellular carcinoma. Dig Dis Sci 1992;37:65-72.
10. Tomimatsu M, Ishiguro N, Taniai M, Okuda M, Saito A, Obata H, et al. Hepatitis C virus antibody in patients with primary liver cancer (hepalocellular carcinoma, cholangiocar-cinoma, and combined hepatocellular-cholangiocarcinoma) in Japan. Cancer 1993;72:683-8.
11. Simonetti RG, Cottone M, Craxi A, Pagliaro L, Rapicetta M, Chionne P, et al. Prevalence of antibodies to hepatitis C virus in hepatocellular carcinoma. Lancet 1989;2:1338.
12. Kaklamani E, Trichopoulos D, Tzonou, Zavitsanos X, Kollmantaki Y, Hatzakis A, et al. Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. JAMA 1991;265:1974-6.
13. Stroffolini T, Chiaramonte M, Tiribelli C, Villa E, Simonetti RG, Rapicetta M, et al. Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinoma: relative risk and population attributable risk from a case - control study in Italy. J Hepatol 1992;16:360-3.
14. Coltorti M, Caporaso N, Persico M, de Sio I, Marmo R, Morisco F, et al. HCV infection and hepatocellular carcinoma in cirrhotics: what is the linkage? Dig Dis Sci 1994;39:1596-7.
15. Lindberg J, Lindholm A. HBsAg-positive Swedish blood donors: natural history and origin of infection. Scand J Infect Dis 1988;20:377-82.
16. Reichard O. Treatment of chronic hepatitis C [dissertation]. Stockholm: Karolinska Institute 1994.
17. van der Poel CL, Cuypers HT, Reesink HW. Hepatitis C virus six years on. Lancet 1994;344:1475-9.
18. Anthony PP. Tumours and tumour-like lesions of the liver and biliary tract. In: MacSween RNM, Anthony PP. Scheuer PJ, editors. Pathology of the liver. 2nd ed. Edinburgh: Churchill Livingstone, 1987:574-645.
19. Regan LS. Screening for hepatocellular carcinoma in high-risk individuals. Arch Intern Med 1989; 149: 1741-4.
20. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan. Lancet 1981;2:1129-33.
21. Yu MW, You SL, Chang AS, Lu SN, Liaw YF, Chen CJ. Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan. Cancer Res 1991;51:5621-5.
22. Okuda K, Fujimoto I, Hanai A, Urano Y. Changing incidence of heptocellular carcinoma in Japan. Cancer Res 1987;47:4967-72.
23. Johnson PJ, Williams R. Hepatitis C antibodies and hepatocellular carcinoma: new clues or a false trail? J Natl Cancer Inst 1990;82:986-7.
24. Sallie R, Di Bisceglie AM. Viral hepatitis and hepatocellular carcinoma. Gastroneterol Clin North Am 1994;23:567-79.
25. Zavitsanos X, Hatzakis A, Kaklamani E, Tzonou R, Toupadaki N, Brocksma C, et al. Association between hepatitis C virus and hepatocellular carcinoma using assays based on structural and nonstructural hepatitis C virus peptides. Cancer Res 1992;52: 5364-7.
26. Di Bisceglie AM, Order SE, Klein JL, Waggoner JG, Sjögren MH, Kuo G, et al. The role of chronic viral hepatitis in hepatocellular carcinoma in the United States. Am J Gastroenterol 1991;86:335-8.
27. Liang TJ, Jeffers LJ, Reddy KR, De Medina M, Parker IT, Cheinquer H, et al. Viral pathogenesis of hepatocellular carcinoma in the United States. Hepatology 1993;18:1326-33.
28. Chuang WL, Chang WY, Lu SN, Su WP, Lin ZY, Chen SC, et al. The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area. Cancer 1992;69: 2052-4.
29. Kew MC, Houghton M, Choo QL, Kuo G. Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma. Lancet 1990;1:873-4.
30. Mets T, Smitz, J, Ngendahayo P, Sabbe L, Bigilimana I, Ngirabatware B. Hepatitis C virus infection in African patients with liver cirrhosis or primary hepatocellular carcinoma. Scand J Gastroenterol 1993;28:331-4.
31. Okuno H, Xie ZC, Lu BY, Qin X, Takasu M, Kano H, et al. A low prevalence of anti-hepatitis C virus antibody in patients with hepatocellular carcinoma in Guangxi province, southern China. Cancer 1994;73:58-62.
32. De Bac C, Stroffolini T, Gaeta GB, Taliani G, Giusti G. Pathogenic factors in cirrhosis with and without hepatocellular carcinoma: a multicenter Italian study. Hepatology 1994;20: 1225-30.
33. Gerber MA. Relation of hepatitis C virus to hepatocellular carcinoma. J Hepatol 1993;17:S108-11.
34. Resnick RH, Koff R. Hepatitis C-related hepatocellular carcinoma. Arch Intern Med 1993;153:1672-7.
35. Tremolada F, Benvegnù L, Casarin C, Tagger A, Alberti A. Antibody to hepatitis C virus in hepatocellular carcinoma. Lancet 1990;1:300-1.
36. Seeff LB, Buskell-Bales Z, Wright EC, Durako SJ, Alter HJ, Iber FL, et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 1992;327:1906-11.
37. Verbaan H, Andersson K, Eriksson S. Intravenous drug abuse - the major route of hepatitis C virus transmission among alcohol-dependent individuals? Scand J Gastroenterol 1993;28: 714-8.
38. Tsukuma H, Hiyama T, Tanaka S, Nakao SJ, Yabuuchi T, Kitamura T, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993: 328:1797-801.
39. Sherlock S. Viruses and hepatocellular carcinoma. Gut 1994; 35:828-32.
40. Tamburro CH, Lee H-M. Primary hepatic cancer in alcoholics. Clin Gastroenterol 1981;10:457-77.